Chronic kidney disease trials recruiting in Missouri

All Chronic kidney disease trials nationally

Cities in Missouri

Recruiting trials in Missouri

• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
  NCT06830629 · Phase: Phase 2 · Ages: 18 Years to 68 Years · Sex: All (male and female) · Missouri: City of Saint Peters, St Louis
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Kansas City, St Louis
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
  NCT07662135 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Kansas City
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Kansas City
• A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
  NCT06749457 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Missouri: Kansas City
• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
  NCT06712654 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Kansas City
• A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
  NCT03619850 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Missouri: Kansas City
• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
  NCT07107945 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Missouri: Kansas City
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Chesterfield
• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
  NCT05457283 · Phase: Phase 3 · Ages: 1 Year to 18 Years · Sex: All (male and female) · Missouri: Kansas City
• A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
  NCT03633708 · Phase: Phase 3 · Ages: 0 Years to 18 Years · Sex: All (male and female) · Missouri: Kansas City
• APOL1 Genetic Testing in African Americans
  NCT05656261 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · Missouri: St Louis
• Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)
  NCT00327860 · Phase: Not specified · Ages: 6 Months to 22 Years · Sex: All (male and female) · Missouri: Kansas City
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Missouri: Ballwin, Bolivar, Branson, Cape Girardeau
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Kansas City
• Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
  NCT03803423 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
  NCT06712407 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• Ferric Citrate and Chronic Kidney Disease in Children
  NCT04741646 · Phase: Phase 2 · Ages: 6 Years to 18 Years · Sex: All (male and female) · Missouri: Kansas City, St Louis
• International (Pediatric) Peritoneal Biobank
  NCT01893710 · Phase: Not specified · Ages: 1 Day to 90 Years · Sex: All (male and female) · Missouri: Kansas City
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
  NCT07494045 · Phase: Phase 2 · Ages: 1 Month to 17 Years · Sex: All (male and female) · Missouri: Kansas City
• Precision Medicine Approaches to Renal Osteodystrophy
  NCT05880914 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
  NCT07083557 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Missouri: Columbia
• SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
  NCT06001827 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Columbia, St Louis
• SAfety of Regional Citrate Anticoagulation (SARCA Study)
  NCT05339139 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
  NCT06217302 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Missouri: St Louis
• Study of BHV-1400 in IgA Nephropathy
  NCT07054684 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Missouri: Chesterfield
• Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
  NCT05287945 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
  NCT07271186 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Missouri: City of Saint Peters, Kansas City
• Testosterone Treatment in Men With Chronic Kidney Disease
  NCT05249634 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: Male · Missouri: St Louis